The SSG was formed in 1979 by physicians and scientists from the Scandinavian countries with a primary interest in tumors of connective tissues.
The goal of the SSG is to advance the care of patients with sarcoma and to increase knowledge of all aspects of the biology of these tumors, including basic and clinical research. The SSG has developed treatment protocols for different sarcoma types and participates in international clinical trials.
At this SSG web-site you can access treatment protocols, find information about previous and future SSG meetings with links to SSG publications.
SSG secretary: Eva-Mari Olofsson
SSG mail address: Eva-Mari.Olofsson@med.lu.se
The Scandinavian Sarcoma Group is a part of Lund University and follows the instructions/regulations for data protection for Lund University.
For more information please, follow this link https://www.lunduniversity.lu.se/about/contact-us/processing-of-personal-data-at-lund-university.
Help us advance the care
of patients with Sarcoma
26th SSG Working Group Meeting
January 31 – February 1, 2022, Malmö
SSG Congress, 40th plenary meeting,
April 26-28 2022, Tampere, Finland
Flyer Tampere 2022
Read the article “Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST).
The article is published in Clinical Sarcoma Research.
This was presented at the ASCO meeting in May, 2020.